Neuromyelitis optica (NMO) is a debilitating neurological disease that is commonly misdiagnosed as multiple sclerosis (MS) and manifests itself in attacks that can cause blindness in one or both eyes, weakness or paralysis in the legs or arms, painful spasms, loss of sensation, and bladder or bowel dysfunction from spinal cord damage.
Now researchers at Mayo Clinic have identified a new therapy for these patients, that appears to stop attacks of inflammation of the eye nerves (optic neuritis) and spinal cord (transverse myelitis). While not a cure, this could possibly lead to improved quality of life for thousands of NMO patients around the world. The research is being presented this week at the American Neurological Association Annual Meeting in Boston.
Read entire news release:NMO